Blinatumomab Intravenous and Insulin Degludec (U-100) Vials
Determining the interaction of Blinatumomab Intravenous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Blinatumomab Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Blinatumomab Intravenous-Insulin degludec and liraglutide
- Blinatumomab Intravenous-Insulin degludec and liraglutide Subcutaneous
- Blinatumomab Intravenous-Insulin degludec Subcutaneous
- Blinatumomab Intravenous-Insulin detemir
- Blinatumomab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Blincyto
- Insulin Degludec (U-100) Vials-Blisovi 24 Fe
- Insulin Degludec (U-100) Vials-Blisovi 24 FE birth control
- Insulin Degludec (U-100) Vials-Blisovi Fe 1.5/30
- Insulin Degludec (U-100) Vials-Blisovi Fe 1/20
- Insulin Degludec (U-100) Vials-Blocadren